The temporal course of COVID-19 anosmia and relation to other clinical symptoms
![Thumbnail](/xmlui/themes/Mirage2//images/restricted.png)
View/ Open
Access
info:eu-repo/semantics/openAccessDate
2021Author
Altundağ, AytuğSaatçi, Özlem
Tekcan Şanlı, Deniz Esin
Arıcı Düz, Özge
Şanlı, Ahmet Necati
Olmuşçelik, Oktay
Temirbekov, Dastan
Kandemirli, Sedat Giray
Batıoğlu Karaaltın, Ayşegül
Metadata
Show full item recordCitation
Altundağ, A., Saatçi, Ö., Tekcan Şanlı, D. E., Arıcı Düz, Ö., Şanlı, A. N., Olmuşçelik, O. ... Batıoğlu Karaaltın, A. (2021). The temporal course of COVID-19 anosmia and relation to other clinical symptoms. European Archives of Oto-Rhino-Laryngology, 278(6), 1891-1897. https://dx.doi.org/10.1007/s00405-020-06496-5Abstract
Objective This study aimed to define the clinical course of anosmia in relation to other clinical symptoms. Methods 135 patients with COVID-19 were reached by phone and subsequently included in the study. Olfactory functions were evaluated using a questionnaire for assessment of self-reported olfactory function. Patients were divided into four subgroups according to the presence of olfactory symptoms and temporal relationship with the other symptoms: group1 had only olfactory complaints (isolated, sudden-onset loss of smell); group2 had sudden-onset loss of smell, followed by COVID-19 related complaints; group3 initially had COVID-19 related complaints, then gradually developed olfactory complaints; and group4 had no olfactory complaints. Results In total, 59.3% of the patients interviewed had olfactory complaints during the disease course. The olfactory dysfunction severity during COVID-19 infection was significantly higher in group1 compared to groups 2 and 3. In groups1-3, the odor scores after recovery from COVID-19 disease were significantly lower compared to the status prior to disease onset. The residual olfactory dysfunction was similar between groups1 and 2, but was more evident than group3. Mean duration for loss of smell was 7.8 +/- 3.1 (2-15) days. Duration of loss of smell was longer in groups1 and 2 than in group3. Odor scores completely returned back to the pre-disease values in 41 (51.2%) patients with olfactory dysfunction. Rate of complete olfactory dysfunction recovery was higher in group3 compared to groups1 and 2. Conclusion In isolated anosmia cases, anosmia is more severe, and complete recovery rates are lower compared to the patients who have other clinical symptoms.
WoS Q Kategorisi
Q2xmlui.dri2xhtml.METS-1.0.item-scopusquality
Q1Source
European Archives of Oto-Rhino-LaryngologyVolume
278Issue
6Collections
- Makale Koleksiyonu [3751]
- PubMed İndeksli Yayınlar Koleksiyonu [4203]
- Scopus İndeksli Yayınlar Koleksiyonu [6522]
- WoS İndeksli Yayınlar Koleksiyonu [6585]